Prevention of nevirapine-associated rash.
Barreiro
P
P
Soriano
V
V
González-Lahoz
J
J
D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000009:adverse effects; D003875:Drug Eruptions / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D019829:Nevirapine / Q000008:administration & dosage* / Q000009:adverse effects
D019380:Anti-HIV Agents; D019829:Nevirapine